Antimicrobial peptides as therapeutic agents: Opportunities and challenges

M Mahlapuu, C Björn, J Ekblom - Critical reviews in biotechnology, 2020 - Taylor & Francis
The rapid development of microbial resistance to conventional antibiotics has accelerated
efforts to find anti-infectives with a novel mode-of-action, which are less prone to bacterial …

Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis

R Pal, M Banerjee, SK Bhadada, AJ Shetty… - Journal of …, 2022 - Springer
Purpose To provide a precise summary and collate the hitherto available clinical evidence
on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients …

A broad-spectrum virus-and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2

H Zhao, KKW To, KH Sze, TTM Yung, M Bian… - Nature …, 2020 - nature.com
The 2019 novel respiratory virus (SARS-CoV-2) causes COVID-19 with rapid global
socioeconomic disruptions and disease burden to healthcare. The COVID-19 and previous …

Supplementation with vitamin D in the COVID-19 pandemic?

F Hadizadeh - Nutrition reviews, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic was declared a public health
emergency of international concern by the World Health Organization. COVID-19 has high …

Broad-spectrum antiviral activity of the amphibian antimicrobial peptide Temporin L and its analogs

C Zannella, A Chianese, L Palomba… - International Journal of …, 2022 - mdpi.com
The COVID-19 pandemic has evidenced the urgent need for the discovery of broad-
spectrum antiviral therapies that could be deployed in the case of future emergence of novel …

Strategies in translating the therapeutic potentials of host defense peptides

DSJ Ting, RW Beuerman, HS Dua… - Frontiers in …, 2020 - frontiersin.org
The golden era of antibiotics, heralded by the discovery of penicillin, has long been
challenged by the emergence of antimicrobial resistance (AMR). Host defense peptides …

Peptidomimetic oligomers targeting membrane phosphatidylserine exhibit broad antiviral activity

PM Tate, V Mastrodomenico, C Cunha… - ACS Infectious …, 2023 - ACS Publications
The development of durable new antiviral therapies is challenging, as viruses can evolve
rapidly to establish resistance and attenuate therapeutic efficacy. New compounds that …

Antiviral and immunomodulatory properties of antimicrobial peptides produced by human keratinocytes

C Chessa, C Bodet, C Jousselin, M Wehbe… - Frontiers in …, 2020 - frontiersin.org
Keratinocytes, the main cells of the epidermis, are the first site of replication as well as the
first line of defense against many viruses such as arboviruses, enteroviruses, herpes …

Epithelial barrier in the nasal mucosa, related risk factors and diseases

R Zhang, L Zhang, P Li, K Pang, H Liu… - International Archives of …, 2023 - karger.com
As the first line of defense against risk factors, the nasal epithelial barrier maintains
homeostasis in nasal mucosa. The composition of the epithelial barrier contains physical …

Do deep learning models make a difference in the identification of antimicrobial peptides?

CR García-Jacas… - Briefings in …, 2022 - academic.oup.com
In the last few decades, antimicrobial peptides (AMPs) have been explored as an alternative
to classical antibiotics, which in turn motivated the development of machine learning models …